Envair Electrodyne (BSE 500246)₹59.56+10.24%Industrial Products
In the Mar 2026 quarter (standalone), Envair Electrodyne reported sales of ₹0 Cr and net profit of −₹0.12 Cr. For the year to Mar 2026, sales were ₹0 Cr and net profit ₹0.12 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.16 | 0.41 | 0.57 | 0.57 | 0.05 | 0.08 | 0.07 | 0.34 | 0.07 | 0.05 | 0.06 | 0.20 |
| Operating Profit | −0.16 | −0.10 | −0.57 | −0.57 | −0.05 | −0.08 | −0.07 | −0.34 | −0.07 | −0.05 | −0.06 | −0.20 |
| OPM % | — | −35.5% | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0.22 | 0.02 | 0.00 | 0.17 | 0.21 | 0.34 | 0.12 | 0.13 | 0.22 | 0.14 | 0.11 | 0.11 |
| Interest | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.03 | −0.09 | −0.61 | −0.41 | 0.13 | 0.23 | 0.02 | −0.22 | 0.12 | 0.06 | 0.02 | −0.10 |
| Tax % | 125.0% | −10.0% | −82.2% | 45.2% | 0.0% | 0.0% | 2,133.4% | 0.0% | 0.0% | 0.0% | 33.3% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.02 | −0.10 | −0.12 | −0.61 | 0.15 | 0.25 | −0.62 | −0.24 | 0.14 | 0.08 | 0.03 | −0.12 |
| EPS (Rs) | −0.01 | −0.18 | −0.23 | −1.28 | 0.29 | 0.51 | −1.30 | −0.49 | 0.27 | 0.14 | 0.03 | −0.23 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.11 | 4.75 | 4.06 | 3.37 | 3.48 | 0.78 | 4.48 | 0.96 | 0.39 | −0.21 | 0.00 | 0.00 |
| Expenses | 4.70 | 4.89 | 4.77 | 6.16 | 4.87 | 2.27 | 5.28 | 1.96 | 1.69 | 0.36 | 0.41 | 0.38 |
| Operating Profit | −0.59 | −0.14 | −0.70 | −2.79 | −1.39 | −1.48 | −0.80 | −0.99 | −1.29 | −0.58 | −0.41 | −0.38 |
| OPM % | −14.5% | −3.1% | −17.4% | −82.9% | −40.1% | −188.6% | −18.0% | −103.1% | −325.0% | — | — | — |
| Other Income | 0.18 | 0.07 | 4.42 | 0.16 | 0.08 | 0.09 | 0.23 | 8.83 | 0.30 | 0.78 | 0.55 | 0.58 |
| Interest | 0.06 | 0.12 | 0.13 | 0.06 | 0.07 | 0.10 | 0.10 | 0.03 | 0.10 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.14 | 0.12 | 0.12 | 0.09 | 0.11 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.62 | −0.30 | 3.46 | −2.77 | −1.48 | −1.59 | −0.76 | 7.76 | −1.09 | 0.17 | 0.11 | 0.10 |
| Tax % | 0.0% | 0.0% | 6.1% | 16.9% | 0.0% | 0.0% | 0.0% | 21.9% | −25.5% | 355.5% | 8.3% | — |
| Exceptional items | 0.00 | 0.00 | 3.98 | 0.00 | 0.00 | 0.00 | 0.00 | 6.98 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.64 | −0.32 | 3.26 | −3.26 | −1.51 | −1.62 | −0.78 | 6.09 | −0.82 | −0.48 | 0.12 | 0.13 |
| EPS (Rs) | −2.06 | −1.01 | 10.68 | −10.67 | −3.22 | −3.46 | −1.65 | 13.09 | −1.74 | −1.00 | 0.23 | 0.21 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 4.63 | 4.65 | 4.65 | 4.64 | 4.64 | 4.64 | 4.64 |
| Reserves | −0.47 | −1.10 | −1.52 | 1.75 | −0.29 | 0.18 | −1.40 | −2.18 | 3.87 | 3.07 | 3.65 | 3.44 |
| Borrowings | 0.12 | 0.40 | 1.11 | 0.66 | 0.61 | 2.23 | 2.48 | 2.76 | 0.00 | 0.00 | 0.01 | 0.00 |
| Other Liabilities | 1.57 | 1.53 | 1.66 | 1.98 | 1.61 | 1.55 | 1.32 | 1.73 | 1.33 | 0.36 | 0.57 | 0.55 |
| Total Liabilities | 4.27 | 3.88 | 4.30 | 7.44 | 4.98 | 8.59 | 7.05 | 6.96 | 9.84 | 8.07 | 8.87 | 8.63 |
| Fixed Assets | 0.91 | 0.83 | 0.77 | 0.81 | 1.09 | 1.04 | 0.94 | 0.85 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.08 | 0.08 | 0.14 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.27 | 2.47 | 2.12 |
| Other Assets | 3.28 | 2.97 | 3.39 | 6.54 | 3.80 | 7.46 | 6.02 | 6.02 | 9.84 | 6.80 | 6.40 | 6.51 |
| Inventories | 0.60 | 0.38 | 0.56 | 0.65 | 0.71 | 0.74 | 0.60 | 0.45 | 0.37 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 1.48 | 1.15 | 1.41 | 1.96 | 0.88 | 1.01 | 0.67 | 0.61 | 1.04 | 0.00 | 0.00 | 0.00 |
| Cash & equivalents | 0.23 | 0.29 | 0.32 | 0.59 | 1.14 | 4.82 | 2.80 | 1.27 | 6.67 | 5.98 | 6.06 | 6.28 |
| Total Assets | 4.27 | 3.88 | 4.30 | 7.44 | 4.98 | 8.59 | 7.05 | 6.96 | 9.84 | 8.07 | 8.87 | 8.63 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.04 | −0.17 | −0.65 | −3.47 | −0.32 | −1.51 | −2.28 | −1.81 | −8.66 | 6.31 | −0.07 | −0.32 |
| Cash from investing activity | −0.12 | −0.08 | −0.09 | 3.85 | −0.84 | −0.09 | −1.48 | 1.57 | 11.69 | −0.82 | −5.77 | 0.42 |
| Cash from financing activity | 0.00 | 0.28 | 0.61 | −0.45 | 1.10 | 5.19 | 0.21 | 0.25 | −2.78 | 0.00 | 0.03 | −0.03 |
| Net cash flow | −0.09 | 0.04 | −0.13 | −0.06 | −0.07 | 3.61 | −3.54 | 0.00 | 0.26 | 5.51 | −5.81 | 0.09 |
| Capex | 0.10 | 0.06 | 0.11 | 0.08 | 0.35 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | −0.07 | −0.22 | −0.75 | −3.56 | −0.66 | −1.57 | −2.28 | −1.81 | −8.62 | 6.29 | −0.05 | −0.30 |
| CFO / OP % | 23.0% | 27.0% | 427.0% | 458.0% | −12.1% | 107.0% | 152.0% | 221.9% | 727.0% | −485.0% | 5.0% | 64.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 97 | 102 | 108 | 176 | 95 | 106 | 313 | 49 | 394 | 0 | 0 | — |
| Inventory days | 72 | 60 | 88 | 119 | 133 | 129 | 405 | 39 | 118 | 0 | 0 | — |
| Days payable | 105 | 101 | 103 | 118 | 118 | 115 | 359 | 58 | 125 | — | — | — |
| Cash conversion cycle | 65 | 62 | 94 | 177 | 112 | 121 | 360 | 32 | 388 | 0 | 0 | — |
| Working capital days | 112 | 59 | 33 | 326 | 33 | 55 | 582 | 190 | 452 | 100 | −133 | — |
| ROCE % | −8.2% | −22.8% | −8.4% | −15.7% | −62.3% | −27.4% | −23.6% | −12.4% | −8.4% | −12.4% | 2.3% | 1.5% |
For the Mar 2026 quarter, Envair Electrodyne reported sales of ₹0 Cr and net profit of −₹0.12 Cr.
Envair Electrodyne's sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0 Cr.
Net profit for the year to Mar 2026 was ₹0.12 Cr, and ₹0.13 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.21.
Envair Electrodyne reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹6.28 Cr.
Cash from operations was −₹0.32 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.30 Cr.